Prevention of deep vein thrombosis in surgical departments;Thromboembolie-prophylaxe in der chirurgie

Chirurg

Volumn 75, Issue 3, 2004, Pages 323-343

  Haas, S ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Guidelines; Prevention of thrombosis; Risk of thrombosis; Surgery; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; ARGATROBAN; DANAPAROID; DESULFATOHIRUDIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRUDIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; PENTASACCHARIDE; PHENPROCOUMON; PROTEIN C; THROMBIN INHIBITOR; WARFARIN; XIMELAGATRAN; FIBRINOLYTIC AGENT; POLYSACCHARIDE;

ANTICOAGULANT THERAPY; COMPRESSION; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HUMAN; LOW DRUG DOSE; MEDICOLEGAL ASPECT; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROPHYLAXIS; REVIEW; RISK FACTOR; SURGICAL RISK; SURGICAL WARD; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT INDICATION; ARTICLE; BANDAGE; COMPARATIVE STUDY; HOSPITAL DEPARTMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; VEIN THROMBOSIS;

ANTICOAGULANTS; BANDAGES; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; PHENPROCOUMON; POLYSACCHARIDES; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS; SURGERY DEPARTMENT, HOSPITAL; VENOUS THROMBOSIS;

EID: 4143151558     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-004-0854-4     Document Type: Review

References (22)

1. Agu O, Hamilton G, Baker D (1999) Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg 86: 992-1004
2. AWMF (2003) Leitlinie zu rückenmarknahen Regionalanästhesien und Thromboembolieprophylaxe/Antikoagulation. Anästhesiol Intensivmed 44: 218-230
3. AWMF (2003) Leitlinie zur stationären und ambulanten Thromboembolieprophylaxe in der Chirurgie und der perioperativen Medizin. AWMF-Leitlinien-Register Nr 003/001
4. Bertina RM, Koeleman BP, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67
5. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP (1995) Resistance to activated protein C and factor V Leiden as risk factor for venous thrombosis. Thromb Haemost 74: 449-453
6. Dahl OE, Aspelin T, Arnesen H et al. (1995) Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res 80: 299-306
7. Dahl OE, Gudmundsen TE, Haukeland L (2000) Late occuring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand 71: 47-50
8. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombosis due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90: 1004-1008
9. Eriksson BI (2003) Clinical experience of melagatran/ximelagatran in major orthopaedic surgery. Thromb Res Suppl 10: S23-912, 13
10. Eriksson BI, Lassen MR (2003) Pentasaccharide in hip-fracture surgery plus investigators: duration of prophylaxis against venous thromboembolism with Fondaparinux after hip fracture surgery: a multicenter, randomised, placebo-controlled, double-blind study. Arch Intern Med 163: 1337-1342
11. Eriksson BI, Agnelli G, Cohen AT et al. (2003) Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thromb Haemost 89: 288-296
12. Geerts WH, Heit JA, Clagett GP et al. (2001) Prevention of venous thromboembolism. Chest 119: 132
13. Gustafsson D, Elg M (2003) The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review. Thromb Res [Suppl 1] 109: S9-15
14. Hirsh J, Warkentin TE, Shaughnessy SG et al. (2001) Heparin and low-molecular-weight heparin. Chest [Suppl] 119: 64S-94S3
15. Hull RD, Pineo GF (1999) Extended prophylaxis against venous thromboembolism following total hip and knee replacement. Haemostasis [Suppl 1] 29: 23-31
16. Mizel MS, Temple HAT, Michelson JD (1998) Thrombo-Oembolism after foot and ankle surgery. A multicenter study. Clin Orthop 348: 180-185
17. Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002) Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 162: 1833-1840
18. Ulsenheimer K (2001) Rechtliche Aspekte bei der Phrophylaxe und Therapie der venösen Thrombose. Chirurg 4: 104-110
19. Virchow R (1856) Phlogose und Thrombose im Gefäß-system. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Meininger, Berlin III: 458-635
20. Warkentin TE, Elavathil LJ, Hayward CP et al. (1997) The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 127: 804-812
21. Wells PS, Lensing AWA, Hirsh J (1996) Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis. Arch Intern Med 154: 67-72
22. Wilson D, Cooke EA, McNally MA, Wilson HK, Yeates A, Mollan RA (2001) Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture. Injury 32: 765-770